vimarsana.com

Page 188 - ஒன்றுபட்டது மாநிலங்களில் கம்பி குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business Highlights

Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business Highlights
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Vicinity Motor Corp Reports First Quarter 2021 Financial Results

Vicinity Motor Corp. Reports First Quarter 2021 Financial Results ACCESSWIRE VANCOUVER, BC / ACCESSWIRE / May 17, 2021 / Vicinity Motor Corp. (TSXV:VMC) (OTCQX:BUSXF) (FRA:6LG) ( Vicinity Motor or the Company ) (formerly Grande West Transportation Group Inc.), a leading supplier of electric, CNG, gas and clean diesel buses, today reported its financial and operational results for the first quarter of 2021. First Quarter 2021 and Subsequent Operational Highlights Revenue grew 588% to $27.3 million in the first quarter of 2021, as compared to $4.0 million in the same year-ago quarter. Delivered 67 buses for the three months ended March 31, 2021, as compared to 6 buses for the three months ended March 31, 2020. Received orders for another ten Vicinity Lightning™ EV buses with expected delivery in 2021.

ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results

ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results ACCESSWIRE 18 May 2021, 06:19 GMT+10 SAN CLEMENTE, CA / ACCESSWIRE / May 17, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, today reported its financial and operational results for the three months ended March 31, 2021. Recent Highlights and Accomplishments Increased revenues by 4.6% compared to non COVID-19 pandemic affected same period in 2019 Continued to implement previously mentioned cost savings plan reducing operating expenses by $1.1 million Improved Non-GAAP loss by $1.6 million Obtained $15.0 million line of credit with instutional investor Received full forgiveness of $1.0 million on PPP loan

Scientific Industries Reports Financial Results for Third Quarter of Fiscal Year 2021

Scientific Industries Reports Financial Results for Third Quarter of Fiscal Year 2021 ACCESSWIRE Benchtop Lab Equipment Reports Strong Revenues and Earnings Company Continues to Invest In Its Bioprocessing Business BOHEMIA, NY / ACCESSWIRE / May 17, 2021 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of optical sensors for non-invasive, real-time monitoring of cell culture systems through its subsidiary Scientific Bioprocessing, Inc. ( SBI ), today reported financial results for the third quarter of fiscal 2021 ended March 31, 2021. 2021 Third Quarter, Nine Months and Recent Highlights: Net revenues were $2.5 million and $7.2 million, an increase of 17% and 16% vs. prior year. Gross profit was $1.4 million and $3.8 million, an increase of 24% and 18% vs. prior year.

iSign Reports First Quarter 2021 Results

iSign Reports First Quarter 2021 Results ACCESSWIRE 17 May 2021, 23:31 GMT+10 SAN JOSE, CA / ACCESSWIRE / May 17, 2021 / iSign Solutions Inc. ( iSIGN ) (OTC PINK:ISGN), a leading supplier of electronic signature and other software solutions enabling secure and cost-effective management of document-based digital transactions, today reported total revenue of $259,000 for the quarter ended March 31, 2021, an increase of $69,000, or 36%, compared to total revenue of $190,000 for the prior year. Our improving performance compared to last year is partially due to the timing of certain maintenance renewals and of certain expenses, and partially to a sustained increase in transaction volume, said Philip Sassower, co-chairman and chief executive officer for iSIGN. We continue making progress in developing new revenue in Europe and remain cautiously optimistic about the company s outlook for accelerating revenue growth throughout 2021 and beyond.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.